Ajanta Pharma Ltd., Mumbai vs. DCIT, CC-7(2), Mumbai
The appeal of the assessee is allowed in terms of our aforesaid observations
ITA 4785/MUM/2019[2015-16]Status: DisposedITAT Mumbai25 May 2021AY 2015-16
Bench: Shri Rajesh Kumar () & Shri Ravish Sood () Ita No.4784 & 4785/Mum/2019 (Assessment Years: 2015-16 & 2016-17) M/S Ajanta Pharma Ltd. Dy. Commissioner Of 98, Ajanta House, Vs. Income-Tax-Central Circle 6(2),19Th Floor, Air India Govt. Industrial Area, Hindustan Naka, Building, Nariman Point, Charkop,Kandivli (West), Mumbai – 400 021. Mumbai – 400 067. Pan No. Aaaca5579P (Appellant) (Respondent)
For Appellant: Shri J.D. Mistri, Senior AdvocateFor Respondent: Shri Rajeev Harit, CIT D.R
Section 143(2)Section 37(1)
…medical practitioners. It was submitted by the ld. A.R that the specific issue in hand i.e as to whether the prohibition by M/s Ajanta Pharma Ltd. Vs. Dy. CIT, Central Circle 6(2), Mumbai Mumbai in the case of DCIT-8(2), Mumbai vs. PHL Pharma (P) Ltd. (2017) 184 TTJ 1 (Mum). The ld. A.R taking us through the aforesaid order drew our attention to the ‘Ground of appeal no. 2’ as was raised before the Tribunal. It was submitted by the ld. A.R that the Tribunal in the aforementioned case of PHL Pharma (P) Ltd. (supra), had held, that the expenditure incurred by the assessee, a pharmaceutical company, for customer re…